Article Information
History
- December 15, 2021.
Article Versions
- You are currently viewing Version 1 of this article (December 15, 2021 - 12:01).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicole A. Doria-Rose1,*,
- Xiaoying Shen2,
- Stephen D Schmidt1,
- Sijy O’Dell1,
- Charlene McDanal2,
- Wenhong Feng2,
- Jin Tong2,
- Amanda Eaton2,
- Maha Maglinao3,
- Haili Tang2,
- Robert L. Atmar4,
- Kirsten E. Lyke5,
- Lingshu Wang1,
- Yi Zhang1,
- Martin R Gaudinski1,
- Walker P Black1,
- Ingelise Gordon1,
- Mercy Guech1,
- Julie E Ledgerwood1,
- John N Misasi1,
- Alicia Widge1,
- Paul C. Roberts6,
- John Beigel6,
- Bette Korber7,
- Rolando Pajon3,
- John R. Mascola1 and
- David C. Montefiori2,*
- 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
- 2Department of Surgery, Duke University Medical Center, Durham NC 27710
- 3Moderna, Inc., Cambridge, MA
- 4Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX 77030
- 5Center for Vaccine Development and Global Health collaborating with the Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201
- 6Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
- 7Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545
- ↵*Corresponding authors; email: monte{at}duke.edu
Posted December 15, 2021.
Booster of mRNA-1273 Vaccine Reduces SARS-CoV-2 Omicron Escape from Neutralizing Antibodies
